in October 2018 when I was 34, I was diagnosed with stage I/II IDC ER/PR+ HER2- low oncotype and ki67 and so went through lumpectomy, radiation, tamoxifen for five years. It was a large tumor near my chest wall, but due to the pathology report + oncotype oncologist said my outcome would be very similar with / without chemo so we opted for no chemo.
In Nov/Dec 2024 I stopped tamoxifen and since it was my first year off my oncologist decided that I should have my annual mammogram in October but then have an MRI in April so I have some form of a scan in 6 months rather than after a year. Thankful for this MRI since it picked up fluid around my lung and so went for PET scan. Again PET scan showed pleura effusion on my right lung and slightly collapsed with mild SUV uptake. Till that point I had zero symptoms other than feeling unusually out of shape when working out / hiking. I got transferred to a pulmonologist to get a VATS pleura removal + biopsy (surgery just over a week ago) and the results are now out - pleura has similar characteristics as my original tumor putting me officially at stage IV. Can I also add the vats is bloody painful - didn’t expect that I feel like lumpectomy was easier!
I’m grateful for my oncologist who wanted me to keep checking although he told on paper it doesn’t make sense for me to have Mets given my original non-aggressive tumor. But the appearance of fluid bothers him and he wanted to make sure so he connected me with his pulmonologist friend.
But it still sucks. It’s also scary. I’m the minority that got Mets.. yes with Mets prognosis isn’t always bad, but given my luck with this recurrence I can’t help not think that I might not beat the odds. I cry just looking at my kids hoping that I can at least see them into early adulthood. I’m hoping after my appt tomorrow with the oncologist to determine the way forward I’ll feel better.
Not sure what the point of my post is. Maybe a bit of just putting it all out there. Anyway, if you know of any positive stories of cases like mine pls share.